Apigenin improves cytotoxicity of antiretroviral drugs against HTLV-1 infected cells through the modulation of AhR signaling.

Dominic SalesEdward LinVictoria StoffelShallyn DicksonZafar K KhanJoris BeldPooja Jain

Published in: NeuroImmune pharmacology and therapeutics (2023)

This study suggest the potential combinatorial use of Apigenin with current first-line antiretrovirals for the benefit of patients affected by HTLV-1 associated pathologies.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
induced apoptosis
human immunodeficiency virus
peritoneal dialysis
hiv infected
prognostic factors
hiv aids
risk assessment
hiv infected patients
human health
antiretroviral therapy